CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF) Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review Can We Use the Intrinsic Left Ventricular Delay (QLV) to Optimize the Pacing Configuration for Cardiac Resynchronization Therapy With a Quadripolar Left Ventricular Lead? Nitrosative stress drives heart failure with preserved ejection fraction Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure HFpEF: From Mechanisms to Therapies Functional Impairment and Medication Burden in Adults With Heart Failure Heart Failure With Preserved Ejection Fraction in the Young

Clinical TrialMarch 17, 2019

JOURNAL:N Engl J Med. Article Link

A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report

MR Mehra, N Uriel, MOMENTUM 3 Investigators. Keywords: advanced heart failure requiring LVAD; bridge or destination therapy; centrifugal-flow pump; axial-flow pump

FULL TEXT PDF